JG

Jan Grimm

BG Biogen International Neuroscience Gmbh: 4 patents #1 of 13Top 8%
UZ Universität Zürich: 4 patents #1 of 25Top 4%
UZ Universitat Zurich: 2 patents #1 of 50Top 2%
BM Biogen Ma: 1 patents #36 of 111Top 35%
NA Neurimmune Holding Ag: 1 patents #1 of 4Top 25%
📍 Stintenberger Straße, CA: #1 of 2 inventorsTop 50%
Overall (2017): #15,594 of 506,227Top 4%
7
Patents 2017

Issued Patents 2017

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
9828420 Method of providing disease-specific binding molecules and targets Roger Nitsch, Christoph Hock, Christoph Esslinger, Marlen Knobloch, Kathrin Tissot 2017-11-28
9771413 Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases Roland Martin, Benoit Combaluzier, Ivan Jelcic 2017-09-26
9670272 Method of providing disease-specific binding molecules and targets Roger Nitsch, Christoph Hock, Christoph Esslinger, Marlen Knobloch, Kathrin Tissot 2017-06-06
9605059 Human anti-tau antibodies Roger Nitsch, Feng Chen, Jean-Luc Baeriswyl, Christoph Hock 2017-03-28
9598484 Human anti-tau antibodies Paul H. Weinreb, Feng Chen, Ellen Garber, Fabio Montrasio 2017-03-21
9587014 TDP-43 specific binding molecules Roger Nitsch, Christoph Hock, Maria Grazia Barenco Montrasio, Fabio Montrasio, Jean-Luc Baeriswyl +3 more 2017-03-07
9580493 Anti-α synuclein binding molecules Andreas Weihofen, Christoph Hock, Roger Nitsch, Lihe Su, Paul H. Weinreb 2017-02-28